BridgeBio Pharma, Inc.
USD73.90
+1.89 (+2.62%)
CEO
Neil Kumar
IPO Date
2019-06-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$72.46
Prev. Close
$72.01
Day Low
$71.78
Day High
$73.99
52W Low
$41.80
52W High
$84.94
Market Cap
$14.47B
Volume
1.24M
| -9.5 |
| 31 Dec 2023 | FY | 73.7% | -6913.9% | 47.5% | -117.7% | -1.28 | 3.32 | -10.2 |
| 31 Dec 2022 | FY | 95.6% | -619.7% | 38.4% | -77.2% | -1.37 | 4.52 | -2.3 |
| 31 Dec 2021 | FY | 95.5% | -806.9% | 64.6% | -55.5% | -1.98 | 6.58 | -4.3 |
| 31 Dec 2020 | FY | 100.0% | -5439.7% | -774.9% | -63.8% | 8.56 | 6.72 | -18.7 |
| 31 Dec 2019 | FY | 93.8% | -642.1% | -63.8% | -41.2% | 0.22 | 9.42 | -14.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 79.7% | -28.1% | -0.33 | 13.67 | -19.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 52.7% | -31.2% | -2.48 | 11.36 | -83.2 |
| -19.1 |
| 30 Sept 2025 | Q3 | 94.6% | -151.4% | 9.5% | -18.3% | -0.96 | 3.88 | -13.5 |
| 30 Jun 2025 | Q2 | 96.7% | -164.5% | 10.2% | -16.8% | -1.50 | 5.19 | -11.3 |
| 31 Mar 2025 | Q1 | 97.7% | -143.5% | 10.2% | -19.0% | -1.13 | 4.57 | -9.8 |
| 31 Dec 2024 | Q4 | 64.6% | -4506.1% | 18.1% | -28.8% | -1.18 | 4.67 | -4.9 |
| 30 Sept 2024 | Q3 | 78.1% | -5931.2% | 13.2% | -24.4% | -1.41 | 3.19 | -7.4 |
| 30 Jun 2024 | Q2 | 72.4% | -3388.2% | 6.7% | -9.2% | -1.58 | 4.59 | -16.1 |
| 31 Mar 2024 | Q1 | 99.7% | -16.7% | 3.4% | -4.1% | -1.65 | 5.54 | -38.0 |
| 31 Dec 2023 | Q4 | 65.7% | -9636.0% | 12.4% | -30.8% | -1.28 | 3.32 | -10.5 |